Cargando…

In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV(1) reversibility

BACKGROUND: A post hoc analysis of two randomized, placebo–controlled, Phase 3 trials of intravenous reslizumab, an anti-interleukin-5 (IL-5) biologic for severe eosinophilic asthma. METHODS: Relationships between baseline blood eosinophil levels (EOS), forced expiratory volume in 1 s (FEV(1)) rever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virchow, J. Christian, Hickey, Lisa, Du, Evelyn, Garin, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168990/ https://www.ncbi.nlm.nih.gov/pubmed/32328116 http://dx.doi.org/10.1186/s13223-020-00424-2

Ejemplares similares

Reslizumab as add-on therapy in patients with refractory asthma
por: Virchow, J Christian, et al.
Publicado: (2020)

Role of biologics in severe eosinophilic asthma – focus on reslizumab
por: Pelaia, Girolamo, et al.
Publicado: (2016)

Update on new biologics for intractable eosinophilic asthma: impact of reslizumab
por: Sahota, Jagdeep, et al.
Publicado: (2018)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab
por: Chu, Hyunwook, et al.
Publicado: (2019)

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
por: Walsh, Garry M
Publicado: (2013)

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
por: Pérez de Llano, Luis A, et al.
Publicado: (2022)

Successful treatment of refractory eosinophilic fasciitis with reslizumab
por: Mortezavi, Mahta, et al.
Publicado: (2020)

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy
por: Brusselle, Guy, et al.
Publicado: (2017)

Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects
por: Máspero, Jorge
Publicado: (2017)

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020)

Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab
por: Nam, Young-Hee
Publicado: (2023)

The effectiveness of Reslizumab in severe asthma treatment: a real-world experience
por: Ibrahim, H., et al.
Publicado: (2019)

FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort
por: Backman, Helena, et al.
Publicado: (2020)

Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
por: Talini, Donatella, et al.
Publicado: (2015)

Reslizumab in the management of poorly controlled asthma: the data so far
por: Maselli, Diego Jose, et al.
Publicado: (2016)

Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
por: Negewo, Netsanet A, et al.
Publicado: (2016)

Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma
por: Solomon, Yenealem, et al.
Publicado: (2023)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV(1) and eosinophilic exacerbations
por: Aziz-Ur-Rehman, Afia, et al.
Publicado: (2017)

Peripheral eosinophilia - is it a predictable factor associated with eosinophilic cholecystitis?
por: Yeom, Seung-Seop, et al.
Publicado: (2012)

Eosinophilic Bronchitis, Eosinophilia Associated Genetic Variants, and Notch Signaling in Asthma
por: Park, Choon-Sik
Publicado: (2010)

Value of peripheral blood eosinophil markers to predict severity of asthma
por: Casciano, Julian, et al.
Publicado: (2016)

Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
por: Walsh, Laura J., et al.
Publicado: (2023)

Recurrent pneumonia with persistent peripheral eosinophilia: Idiopathic chronic eosinophilic pneumonia
por: Wolfley, Graey, et al.
Publicado: (2021)

Eosinophilic gastritis without peripheral eosinophilia and atopy: A case report
por: Mishra, Aakash, et al.
Publicado: (2022)

Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives
por: Padilla Galo, Alicia, et al.
Publicado: (2018)

Nonepisodic angioedema with eosinophilia with remarkably high blood eosinophil counts
por: Hara, Kenji, et al.
Publicado: (2022)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
por: Gómez-Bastero Fernández, Ana, et al.
Publicado: (2022)

Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion: A case report
por: Huang, Jing, et al.
Publicado: (2018)

Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis
por: Charles, David, et al.
Publicado: (2022)

Association between peripheral blood/bronchoalveolar lavage eosinophilia and significant oxygen requirements in patients with acute eosinophilic pneumonia
por: Choi, Joon Young, et al.
Publicado: (2020)

Eosinophil-mediated inflammation in the absence of eosinophilia
por: Miyabe, Yui, et al.
Publicado: (2021)

Peripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosis
por: Grzegorczyk, Barbara, et al.
Publicado: (2014)

Evaluation of peripheral blood eosinophilia, serum ECP levels of eosinophils in inflammatory infiltrates of gastric mucosa in food allergy patients
por: Graczyk, Malgorzata, et al.
Publicado: (2011)

Short-term pulmonary infiltrate with eosinophilia caused by asthma: a phenotype of severe, eosinophilic asthma? Five cases and a review of the literature
por: Song, Min, et al.
Publicado: (2019)

Absence of esophageal eosinophilia in a toddler with severe eosinophilic esophagitis
por: Loh, Wenyin, et al.
Publicado: (2017)

Asthmatic adult with marked blood eosinophilia: is it truly asthma?
por: Tan, Shera, et al.
Publicado: (2018)

Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
por: Li, Lisha, et al.
Publicado: (2021)

Evaluation of asthma severity: Relevance of total serum IgE, sputum and peripheral eosinophilia
por: Mahesh, PA
Publicado: (2017)

Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
por: Pabón-Cartagena, Gabriela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_338ls92fov2e9ckhpldokpa23v